Simple urine test could spot bladder cancer early, avoiding unnecessary scopes

NCT ID NCT03193541

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new urine test that looks for specific proteins to detect bladder cancer in people who have microscopic blood in their urine (not visible to the naked eye). The goal is to see if this simple, non-invasive test can accurately identify cancer, potentially reducing the need for invasive procedures like cystoscopy. About 900 adults with microscopic hematuria will provide urine samples, and the test results will be compared to standard cystoscopy findings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cedars-Sinai Medical Center

    RECRUITING

    Los Angeles, California, 90048, United States

  • Hoag Memorial Hospital Presbyterian

    RECRUITING

    Newport Beach, California, 92663, United States

  • Nara Medical University

    RECRUITING

    Nara, Japan

  • Nara Prefecture Seiwa Medical Center

    RECRUITING

    Nara, Nara, 636-0802, Japan

  • UCLA Medical Center

    RECRUITING

    Los Angeles, California, 90095, United States

  • UT Southwestern Medical Center at Dallas

    RECRUITING

    Dallas, Texas, 75390, United States

  • University of Rochester Medical Center

    RECRUITING

    Rochester, New York, 14620, United States

  • VA Long Beach Healthcare System

    RECRUITING

    Long Beach, California, 90822, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.